• Something wrong with this record ?

Vitamin K Status Based on K1, MK-4, MK-7, and Undercarboxylated Prothrombin Levels in Adolescent and Adult Patients with Cystic Fibrosis: A Cross-Sectional Study

P. Krzyżanowska-Jankowska, J. Nowak, M. Karaźniewicz-Łada, M. Jamka, E. Klapkova, S. Kurek, S. Drzymała-Czyż, A. Lisowska, I. Wojsyk-Banaszak, W. Skorupa, J. Szydłowski, R. Prusa, J. Walkowiak

. 2024 ; 16 (9) : . [pub] 20240429

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc24014238

Grant support
JAK0000079 Poznan University of Medical Sciences

The available evidence on vitamin K status in cystic fibrosis (CF) is scarce, lacking data on vitamin K2 (menaquinones-MK). Therefore, we assessed vitamin K1, MK-4 and MK-7 concentrations (LC-MS/MS) in 63 pancreatic insufficient and modulator naïve CF patients, and compared to 61 healthy subjects (HS). Vitamin K1 levels did not differ between studied groups. MK-4 concentrations were higher (median <1st-3rd quartile>: 0.778 <0.589-1.086> vs. 0.349 <0.256-0.469>, p < 0.0001) and MK-7 levels lower (0.150 <0.094-0.259> vs. 0.231 <0.191-0.315>, p = 0.0007) in CF patients than in HS. MK-7 concentrations were higher in CF patients receiving K1 and MK-7 supplementation than in those receiving vitamin K1 alone or no supplementation. Moreover, vitamin K1 concentrations depended on the supplementation regime. Based on multivariate logistic regression analysis, we have found that MK-7 supplementation dose has been the only predictive factor for MK-7 levels. In conclusion, vitamin K1 levels in CF are low if not currently supplemented. MK-4 concentrations in CF patients supplemented with large doses of vitamin K1 are higher than in HS. MK-7 levels in CF subjects not receiving MK-7 supplementation, with no regard to vitamin K1 supplementation, are low. There do not seem to be any good clinical predictive factors for vitamin K status.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24014238
003      
CZ-PrNML
005      
20240905134305.0
007      
ta
008      
240725s2024 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/nu16091337 $2 doi
035    __
$a (PubMed)38732584
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Krzyżanowska-Jankowska, Patrycja $u Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Szpitalna Street 27/33, 60-572 Poznan, Poland $1 https://orcid.org/0000000186769803
245    10
$a Vitamin K Status Based on K1, MK-4, MK-7, and Undercarboxylated Prothrombin Levels in Adolescent and Adult Patients with Cystic Fibrosis: A Cross-Sectional Study / $c P. Krzyżanowska-Jankowska, J. Nowak, M. Karaźniewicz-Łada, M. Jamka, E. Klapkova, S. Kurek, S. Drzymała-Czyż, A. Lisowska, I. Wojsyk-Banaszak, W. Skorupa, J. Szydłowski, R. Prusa, J. Walkowiak
520    9_
$a The available evidence on vitamin K status in cystic fibrosis (CF) is scarce, lacking data on vitamin K2 (menaquinones-MK). Therefore, we assessed vitamin K1, MK-4 and MK-7 concentrations (LC-MS/MS) in 63 pancreatic insufficient and modulator naïve CF patients, and compared to 61 healthy subjects (HS). Vitamin K1 levels did not differ between studied groups. MK-4 concentrations were higher (median <1st-3rd quartile>: 0.778 <0.589-1.086> vs. 0.349 <0.256-0.469>, p < 0.0001) and MK-7 levels lower (0.150 <0.094-0.259> vs. 0.231 <0.191-0.315>, p = 0.0007) in CF patients than in HS. MK-7 concentrations were higher in CF patients receiving K1 and MK-7 supplementation than in those receiving vitamin K1 alone or no supplementation. Moreover, vitamin K1 concentrations depended on the supplementation regime. Based on multivariate logistic regression analysis, we have found that MK-7 supplementation dose has been the only predictive factor for MK-7 levels. In conclusion, vitamin K1 levels in CF are low if not currently supplemented. MK-4 concentrations in CF patients supplemented with large doses of vitamin K1 are higher than in HS. MK-7 levels in CF subjects not receiving MK-7 supplementation, with no regard to vitamin K1 supplementation, are low. There do not seem to be any good clinical predictive factors for vitamin K status.
650    _2
$a lidé $7 D006801
650    12
$a cystická fibróza $x krev $7 D003550
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    12
$a vitamin K 2 $x krev $x analogy a deriváty $7 D024482
650    _2
$a průřezové studie $7 D003430
650    12
$a protrombin $x analýza $7 D011516
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    12
$a vitamin K 1 $x aplikace a dávkování $x krev $7 D010837
650    _2
$a mladý dospělý $7 D055815
650    _2
$a nutriční stav $7 D009752
650    _2
$a potravní doplňky $7 D019587
650    _2
$a nedostatek vitaminu K $x krev $7 D014813
650    _2
$a vitamin K $x krev $7 D014812
655    _2
$a časopisecké články $7 D016428
700    1_
$a Nowak, Jan $u Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Szpitalna Street 27/33, 60-572 Poznan, Poland $1 https://orcid.org/0000000309532188
700    1_
$a Karaźniewicz-Łada, Marta $u Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, Rokietnicka Street 3, 60-806 Poznan, Poland $1 https://orcid.org/0000000340917035
700    1_
$a Jamka, Małgorzata $u Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Szpitalna Street 27/33, 60-572 Poznan, Poland $1 https://orcid.org/0000000202576180
700    1_
$a Klapkova, Eva $u Department of Medical Chemistry and Clinical Biochemistry, 2nd Faculty of Medicine, Charles University, V Úvalu 84, 150 06 Prague, Czech Republic
700    1_
$a Kurek, Szymon $u Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Szpitalna Street 27/33, 60-572 Poznan, Poland
700    1_
$a Drzymała-Czyż, Sławomira $u Department of Bromatology, Poznan University of Medical Sciences, Rokietnicka Street 3, 60-806 Poznan, Poland $1 https://orcid.org/0000000182915439
700    1_
$a Lisowska, Aleksandra $u Department of Pediatric Diabetes, Auxology and Obesity, Poznan University of Medical Sciences, Szpitalna Street 27/33, 60-572 Poznan, Poland
700    1_
$a Wojsyk-Banaszak, Irena $u Department of Pneumonology, Allergology and Clinical Immunology, Poznan University of Medical Sciences, Szpitalna Street 27/33, 60-572 Poznan, Poland $1 https://orcid.org/0000000167241499
700    1_
$a Skorupa, Wojciech $u Department of Lung Diseases, Institute for Tuberculosis and Lung Diseases, Plocka Street 26, 01-138 Warsaw, Poland
700    1_
$a Szydłowski, Jarosław $u Department of Pediatric Otolaryngology, Poznan University of Medical Sciences, Szpitalna Street 27/33, 60-572 Poznan, Poland
700    1_
$a Prusa, Richard $u Department of Medical Chemistry and Clinical Biochemistry, 2nd Faculty of Medicine, Charles University, V Úvalu 84, 150 06 Prague, Czech Republic
700    1_
$a Walkowiak, Jarosław $u Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Szpitalna Street 27/33, 60-572 Poznan, Poland $1 https://orcid.org/0000000158135707
773    0_
$w MED00189563 $t Nutrients $x 2072-6643 $g Roč. 16, č. 9 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38732584 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134259 $b ABA008
999    __
$a ok $b bmc $g 2143810 $s 1226104
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 16 $c 9 $e 20240429 $i 2072-6643 $m Nutrients $n Nutrients $x MED00189563
GRA    __
$a JAK0000079 $p Poznan University of Medical Sciences
LZP    __
$a Pubmed-20240725

Find record

Citation metrics

Archiving options